CoChat

Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function

Open access
Hosp, Fabian, Gutiérrez-Ángel, Sara, Schaefer, Martin H., Cox, Jürgen, Meissner, Felix, Hipp, Mark S., Hartl, F.-Ulrich, Klein, Rüdiger, Dudanova, Irina, Mann, Matthias · 2017 · Cell Reports
Cited by 123

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Aggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington's disease (HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates and how they lead to neuronal dysfunction is not well understood. We employed mass spectrometry (MS)-based quantitative proteomics to dissect spatiotemporal mechanisms of neurodegeneration using the R6/2 mouse model of HD. Extensive remodeling of the soluble brain proteome correlated with insoluble aggregate formation during disease progression. In-depth and quantitative characterization of the aggregates uncovered an unprecedented complexity of several hundred proteins. Sequestration to aggregates depended on protein expression levels and sequence features such as low-complexity regions or coiled-coil domains. In a cell-based HD model, overexpression of a subset of the sequestered proteins in most cases rescued viability and reduced aggregate size. Our spatiotemporally resolved proteome resource of HD progression indicates that widespread loss of cellular protein function contributes to aggregate-mediated toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2017.10.097

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 50

  1. Acuña, 2013, A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice, Nat. Commun., 4, 2917, 10.1038/ncomms3917 · DOI · Paper page
  2. Baldo, 2012, TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in Huntington’s disease, Chem. Biol., 19, 264, 10.1016/j.chembiol.2011.12.020 · DOI
  3. Byrne, 2016, Cerebrospinal fluid biomarkers for Huntington’s disease, J. Huntingtons Dis., 5, 1, 10.3233/JHD-160196 · DOI · Paper page
  4. Carapito, 2015, A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia, Mov. Disord., 30, 423, 10.1002/mds.26115 · DOI · Paper page
  5. Carter, 1999, Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation, J. Neurosci., 19, 3248, 10.1523/JNEUROSCI.19-08-03248.1999 · DOI · Paper page
  6. Chen, 2013, Dopamine imbalance in Huntington’s disease: a mechanism for the lack of behavioral flexibility, Front. Neurosci., 7, 114, 10.3389/fnins.2013.00114 · DOI · Paper page
  7. Culver, 2012, Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis, J. Biol. Chem., 287, 21599, 10.1074/jbc.M112.359307 · DOI · Paper page
  8. Cumberworth, 2013, Promiscuity as a functional trait: intrinsically disordered regions as central players of interactomes, Biochem. J., 454, 361, 10.1042/BJ20130545 · DOI · Paper page
  9. Cummings, 2009, Alterations in cortical excitation and inhibition in genetic mouse models of Huntington’s disease, J. Neurosci., 29, 10371, 10.1523/JNEUROSCI.1592-09.2009 · DOI · Paper page
  10. Dalrymple, 2007, Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates, J. Proteome Res., 6, 2833, 10.1021/pr0700753 · DOI · Paper page
  11. Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 · DOI · Paper page
  12. DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 · DOI · Paper page
  13. Doi, 2004, Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates, FEBS Lett., 571, 171, 10.1016/j.febslet.2004.06.077 · DOI · Paper page
  14. Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington’s disease, Science, 296, 2238, 10.1126/science.1072613 · DOI · Paper page
  15. Fang, 2009, Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease, Mol. Cell. Proteomics, 8, 451, 10.1074/mcp.M800231-MCP200 · DOI · Paper page
  16. Fiumara, 2010, Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins, Cell, 143, 1121, 10.1016/j.cell.2010.11.042 · DOI · Paper page
  17. Galli, 2014, Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice, Nat. Commun., 5, 4992, 10.1038/ncomms5992 · DOI · Paper page
  18. Gerfen, 2011, Modulation of striatal projection systems by dopamine, Annu. Rev. Neurosci., 34, 441, 10.1146/annurev-neuro-061010-113641 · DOI · Paper page
  19. Giampà, 2010, Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington’s disease, PLoS ONE, 5, e13417, 10.1371/journal.pone.0013417 · DOI · Paper page
  20. Hageman, 2010, A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation, Mol. Cell, 37, 355, 10.1016/j.molcel.2010.01.001 · DOI · Paper page
  21. Han, 2012, Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies, Cell, 149, 768, 10.1016/j.cell.2012.04.016 · DOI · Paper page
  22. Hazeki, 2000, Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates, Biochem. Biophys. Res. Commun., 277, 386, 10.1006/bbrc.2000.3682 · DOI
  23. Hosp, 2015, Quantitative interaction proteomics of neurodegenerative disease proteins, Cell Rep., 11, 1134, 10.1016/j.celrep.2015.04.030 · DOI · Paper page
  24. Jain, 2016, ATPase-modulated stress granules contain a diverse proteome and substructure, Cell, 164, 487, 10.1016/j.cell.2015.12.038 · DOI · Paper page
  25. Jiang, 2011, Neuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets, Nat. Med., 18, 153, 10.1038/nm.2558 · DOI · Paper page
  26. Kaltenbach, 2007, Huntingtin interacting proteins are genetic modifiers of neurodegeneration, PLoS Genet., 3, e82, 10.1371/journal.pgen.0030082 · DOI · Paper page
  27. Kim, 2016, Soluble oligomers of polyQ-expanded huntingtin target a multiplicity of key cellular factors, Mol. Cell, 63, 951, 10.1016/j.molcel.2016.07.022 · DOI · Paper page
  28. Kroksveen, 2011, Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics, J. Proteomics, 74, 371, 10.1016/j.jprot.2010.11.010 · DOI
  29. Li, 2004, Huntingtin-protein interactions and the pathogenesis of Huntington’s disease, Trends Genet., 20, 146, 10.1016/j.tig.2004.01.008 · DOI · Paper page
  30. Li, 2013, Stress granules as crucibles of ALS pathogenesis, J. Cell Biol., 201, 361, 10.1083/jcb.201302044 · DOI · Paper page
  31. Martinez, 2016, Protein-RNA networks regulated by normal and ALS-associated mutant HNRNPA2B1 in the nervous system, Neuron, 92, 780, 10.1016/j.neuron.2016.09.050 · DOI · Paper page
  32. Meade, 2002, Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice, J. Comp. Neurol., 449, 241, 10.1002/cne.10295 · DOI · Paper page
  33. Mitsui, 2002, Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins, J. Neurosci., 22, 9267, 10.1523/JNEUROSCI.22-21-09267.2002 · DOI · Paper page
  34. Olzscha, 2011, Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions, Cell, 144, 67, 10.1016/j.cell.2010.11.050 · DOI · Paper page
  35. Orr, 2007, Trinucleotide repeat disorders, Annu. Rev. Neurosci., 30, 575, 10.1146/annurev.neuro.29.051605.113042 · DOI · Paper page
  36. Ortega, 2014, Ubiquitin-proteasome system involvement in Huntington’s disease, Front. Mol. Neurosci., 7, 77, 10.3389/fnmol.2014.00077 · DOI · Paper page
  37. Ossovskaya, 2004, Protease-activated receptors: contribution to physiology and disease, Physiol. Rev., 84, 579, 10.1152/physrev.00028.2003 · DOI · Paper page
  38. Russell, 2014, The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease, JAMA Neurol., 71, 1520, 10.1001/jamaneurol.2014.1954 · DOI
  39. Saudou, 2016, The biology of huntingtin, Neuron, 89, 910, 10.1016/j.neuron.2016.02.003 · DOI · Paper page
  40. Schaefer, 2012, Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks, Nucleic Acids Res., 40, 4273, 10.1093/nar/gks011 · DOI · Paper page
  41. Scheltema, 2012, SprayQc: a real-time LC-MS/MS quality monitoring system to maximize uptime using off the shelf components, J. Proteome Res., 11, 3458, 10.1021/pr201219e · DOI · Paper page
  42. Sharma, 2012, Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response, Mol. Cell. Proteomics, 11, 10.1074/mcp.M111.014654 · DOI · Paper page
  43. Shimohata, 2000, Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription, Nat. Genet., 26, 29, 10.1038/79139 · DOI · Paper page
  44. Stroedicke, 2015, Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity, Genome Res., 25, 701, 10.1101/gr.182444.114 · DOI
  45. 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
  46. Vonsattel, 1998, Huntington disease, J. Neuropathol. Exp. Neurol., 57, 369, 10.1097/00005072-199805000-00001 · DOI · Paper page
  47. Walther, 2011, Accurate quantification of more than 4000 mouse tissue proteins reveals minimal proteome changes during aging, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.004523 · DOI · Paper page
  48. Winklhofer, 2008, The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases, EMBO J., 27, 336, 10.1038/sj.emboj.7601930 · DOI · Paper page
  49. Woodman, 2007, The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes, Brain Res. Bull., 72, 83, 10.1016/j.brainresbull.2006.11.004 · DOI · Paper page
  50. Wyttenbach, 2001, Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease, Hum. Mol. Genet., 10, 1829, 10.1093/hmg/10.17.1829 · DOI · Paper page

Cited by

See all 123

Metadata

Authors
Hosp, F., Gutiérrez-Ángel, S., Schaefer, M. H., Cox, J., Meissner, F., Hipp, M. S., Hartl, F.-U., Klein, R., Dudanova, I., & Mann, M.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2017-11
Volume
21
Issue
8
Pages
2291-2303
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2769102984
Cited by
123
References
18
FWCI
5.64
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Munich Cluster for Systems Neurology
  • European Research Council Synergy (ERC-2012-SyG_318987-ToPAG)
  • Max Planck Society for the Advancement of Science

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function. https://app.cochat.ai/papers/10.1016/j.celrep.2017.10.097
The paper
Hosp, F., Gutiérrez-Ángel, S., Schaefer, M. H., Cox, J., Meissner, F., Hipp, M. S., Hartl, F.-U., Klein, R., Dudanova, I., & Mann, M. (2017). Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function. Cell Reports. https://doi.org/10.1016/j.celrep.2017.10.097

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.